ERRFI1 and neoplasm: Down-regulated expression of MIG-6 has been observed in human EEC [49,50,51], lung cancer [52], papillary thyroid cancer [53], and breast carcinoma [54,55,56], suggesting that MIG-6 has a human tumor-suppressor role.